{"id":"https://openalex.org/W2089768466","doi":"https://doi.org/10.1089/mdr.1995.1.223","title":"Quinupristin/Dalfopristin: Spectrum of Activity, Pharmacokinetics, and Initial Clinical Experience","display_name":"Quinupristin/Dalfopristin: Spectrum of Activity, Pharmacokinetics, and Initial Clinical Experience","alternate_titles":[],"publication_year":1995,"publication_date":"1995-10-01","ids":{"openalex":"https://openalex.org/W2089768466","doi":"https://doi.org/10.1089/mdr.1995.1.223","mag":"2089768466","pmid":"https://pubmed.ncbi.nlm.nih.gov/9158779"},"language":"en","primary_location":{"id":"doi:10.1089/mdr.1995.1.223","doi":"https://doi.org/10.1089/mdr.1995.1.223","is_oa":false,"landing_page_url":"https://doi.org/10.1089/mdr.1995.1.223","pdf_url":null,"source":{"id":"https://openalex.org/S178647319","display_name":"Microbial Drug Resistance","issn_l":"1076-6294","issn":["1076-6294","1931-8448"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Microbial Drug Resistance","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2089768466"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072357134","display_name":"Donald E. Low","orcid":"https://orcid.org/0000-0002-3735-0958","observed_orcids":["https://orcid.org/0000-0002-3735-0958"]},"institutions":[{"id":"https://openalex.org/I1291836623","display_name":"Mount Sinai Hospital","ror":"https://ror.org/05deks119","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1291836623","https://openalex.org/I4210130843"]}],"countries":["CA"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Donald E. Low","raw_affiliation_strings":["Department of Microbiology, Mount Sinai Hospital, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Mount Sinai Hospital, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I1291836623"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5072357134"],"corresponding_institution_ids":["https://openalex.org/I1291836623"],"apc_list":null,"apc_paid":null,"fwci":5.4397,"has_fulltext":false,"cited_by_count":77,"citation_normalized_percentile":{"value":0.95789474,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"1","issue":"3","first_page":"223","last_page":"234"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.6596999764442444,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.6596999764442444,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.18070000410079956,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.09359999746084213,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/quinupristin-dalfopristin","display_name":"quinupristin/dalfopristin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/streptogramins","display_name":"streptogramins","score":0.9810000061988831},{"id":"https://openalex.org/keywords/multidrug-resistant-infections","display_name":"multidrug-resistant infections","score":0.7379999756813049},{"id":"https://openalex.org/keywords/methicillin-resistant-staphylococcus-aureus","display_name":"methicillin-resistant Staphylococcus aureus","score":0.9620000123977661},{"id":"https://openalex.org/keywords/vancomycin-resistant-enterococci","display_name":"vancomycin-resistant enterococci","score":0.9229999780654907},{"id":"https://openalex.org/keywords/coagulase-negative-staphylococci","display_name":"coagulase-negative staphylococci","score":0.9160000085830688},{"id":"https://openalex.org/keywords/penicillin-resistant-pneumococci","display_name":"penicillin-resistant pneumococci","score":0.9819999933242798},{"id":"https://openalex.org/keywords/gram-positive-cocci","display_name":"Gram-positive cocci","score":0.828000009059906},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7870000004768372},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.7599999904632568},{"id":"https://openalex.org/keywords/postantibiotic-effect","display_name":"post-antibiotic effect","score":0.8579999804496765},{"id":"https://openalex.org/keywords/anaerobic-infections","display_name":"anaerobic infections","score":0.8399999737739563},{"id":"https://openalex.org/keywords/respiratory-pathogens","display_name":"respiratory pathogens","score":0.5830000042915344}],"concepts":[{"id":"https://openalex.org/C2780944852","wikidata":"https://www.wikidata.org/wiki/Q7272542","display_name":"Quinupristin","level":5,"score":0.9857195615768433},{"id":"https://openalex.org/C2777874012","wikidata":"https://www.wikidata.org/wiki/Q5210829","display_name":"Dalfopristin","level":5,"score":0.979870080947876},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.6807519793510437},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.5087721943855286},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.47658559679985046},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.41476595401763916},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.39122718572616577},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.09449535608291626},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001419","descriptor_name":"Bacteria","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014769","descriptor_name":"Virginiamycin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014769","descriptor_name":"Virginiamycin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014769","descriptor_name":"Virginiamycin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1089/mdr.1995.1.223","doi":"https://doi.org/10.1089/mdr.1995.1.223","is_oa":false,"landing_page_url":"https://doi.org/10.1089/mdr.1995.1.223","pdf_url":null,"source":{"id":"https://openalex.org/S178647319","display_name":"Microbial Drug Resistance","issn_l":"1076-6294","issn":["1076-6294","1931-8448"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Microbial Drug Resistance","raw_type":"journal-article"},{"id":"pmid:9158779","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9158779","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Microbial drug resistance (Larchmont, N.Y.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W1858841438","https://openalex.org/W1963937797","https://openalex.org/W1964024424","https://openalex.org/W1966835810","https://openalex.org/W1967704783","https://openalex.org/W1976885209","https://openalex.org/W1984400667","https://openalex.org/W1988907123","https://openalex.org/W1991432772","https://openalex.org/W2000311763","https://openalex.org/W2001525095","https://openalex.org/W2020035349","https://openalex.org/W2022440354","https://openalex.org/W2032135320","https://openalex.org/W2035320583","https://openalex.org/W2039206959","https://openalex.org/W2051164931","https://openalex.org/W2051191407","https://openalex.org/W2052954259","https://openalex.org/W2054350590","https://openalex.org/W2056104244","https://openalex.org/W2065837503","https://openalex.org/W2070214202","https://openalex.org/W2070398785","https://openalex.org/W2076115151","https://openalex.org/W2089483186","https://openalex.org/W2092448822","https://openalex.org/W2093501573","https://openalex.org/W2102510389","https://openalex.org/W2112117925","https://openalex.org/W2114830802","https://openalex.org/W2127326403","https://openalex.org/W2154463216","https://openalex.org/W2158429523","https://openalex.org/W2161863616","https://openalex.org/W2164277924","https://openalex.org/W2164576845","https://openalex.org/W2166347078","https://openalex.org/W2318386528","https://openalex.org/W2327946322","https://openalex.org/W2332255640","https://openalex.org/W2434946718","https://openalex.org/W4237112785","https://openalex.org/W4253754576"],"related_works":["https://openalex.org/W2131913551","https://openalex.org/W2025355265","https://openalex.org/W3190671992","https://openalex.org/W2149094731","https://openalex.org/W1771336156","https://openalex.org/W2410224389","https://openalex.org/W2005776364","https://openalex.org/W2082578501","https://openalex.org/W1985635789","https://openalex.org/W2474690725"],"abstract_inverted_index":{"In":[0],"recent":[1],"years,":[2],"the":[3,19,48,56,61,115,132],"prevalence":[4],"of":[5,9,18,63,67,78,84,89,117],"multiple":[6],"drug-resistant":[7],"strains":[8],"common":[10,95],"Gram-positive":[11,93],"pathogens":[12],"has":[13],"grown":[14],"in":[15,38,45],"many":[16],"regions":[17],"world.":[20],"Increasingly,":[21],"methicillin-resistant":[22,127],"Staphylococcus":[23],"aureus,":[24],"coagulase-negative":[25],"staphylococci,":[26],"vancomycin-resistant":[27,124],"enterococci,":[28],"and":[29,40,98,100,126,135],"penicillin-resistant":[30],"pneumococci":[31],"have":[32],"been":[33],"identified":[34],"as":[35],"causative":[36],"organisms":[37],"serious":[39],"life-threatening":[41],"infections.":[42],"This":[43,129],"increase":[44],"resistance":[46],"highlights":[47],"need":[49],"for":[50,114],"new":[51],"antimicrobial":[52],"agents":[53],"to":[54,106,123,140],"expand":[55],"therapeutic":[57],"armamentarium.":[58],"Quinupristin/dalfopristin":[59],"is":[60,72],"first":[62],"a":[64,75],"unique":[65,76],"class":[66],"antibiotics":[68],"called":[69],"streptogramins.":[70],"It":[71],"characterized":[73],"by":[74],"mechanism":[77],"action,":[79],"intracellular":[80],"activity,":[81],"synergistic":[82],"activity":[83,90],"its":[85],"components,":[86],"broad":[87],"spectrum":[88],"against":[91],"most":[92],"cocci,":[94],"respiratory":[96],"pathogens,":[97],"anaerobes,":[99],"demonstrated":[101],"postantibiotic":[102],"effect.":[103],"Clinical":[104],"evidence":[105],"date":[107],"indicates":[108],"that":[109],"quinupristin/dalfopristin":[110,139],"may":[111],"be":[112],"effective":[113],"treatment":[116],"multidrug-resistant":[118],"infections,":[119],"especially":[120],"those":[121],"due":[122],"enterococci":[125],"staphylococci.":[128],"article":[130],"reviews":[131],"pharmacology,":[133],"microbiology,":[134],"clinical":[136],"experience":[137],"with":[138],"date.":[141]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2089768466","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
